Research Article
Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis
Figure 3
Images from a 45-year-old man with advanced hepatocellular carcinoma (HCC) with Vp3 portal vein tumor thrombosis (PVTT). (a–c) The right main portal vein thrombosis and a huge lesion () in the right lobe of the liver were revealed by MRI T2 phase and contrast-enhanced MRI (CE-MRI) before chemoembolization and hepatic arterial infusion chemotherapy (TACE-HAIC) (arrows). (b–d) After six cycles of TACE-HAIC, MRI T2 phase and CE-MRI imaging showed that the tumor thrombosis and liver lesion were further reduced in size (arrows) with almost no enhancement. The overall survival (OS) was 93.1 months.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |